Emodin suppresses alkali burn-induced corneal inflammation and neovascularization by the vascular endothelial growth factor receptor 2 signaling pathway

J Tradit Chin Med. 2024 Apr;44(2):268-276. doi: 10.19852/j.cnki.jtcm.20240203.005.

Abstract

Objective: To investigate the effects of emodin on alkali burn-induced corneal inflammation and neovascularization.

Methods: The ability of emodin to target vascular endothelial growth factor receptor 2 (VEGFR2) was predicted by molecular docking. The effects of emodin on the invasion, migration, and proliferation of human umbilical vein endothelial cells (HUVEC) were determined by cell counting kit-8, Transwell, and tube formation assays. Analysis of apoptosis was performed by flow cytometry. CD31 levels were examined by immunofluorescence. The abundance and phosphorylation state of VEGFR2, protein kinase B (Akt), signal transducer and activator of transcription 3 (STAT3), and P38 were examined by immunoblot analysis. Corneal alkali burn was performed on 40 mice. Animals were divided randomly into two groups, and the alkali-burned eyes were then treated with drops of either 10 μM emodin or phosphate buffered saline (PBS) four times a day. Slit-lamp microscopy was used to evaluate inflammation and corneal neovascularization (CNV) in all eyes on Days 0, 7, 10, and 14. The mice were killed humanely 14 d after the alkali burn, and their corneas were removed and preserved at -80 ℃ until histological study or protein extraction.

Results: Molecular docking confirmed that emodin was able to target VEGFR2. The findings revealed that emodin decreased the invasion, migration, angiogenesis, and proliferation of HUVEC in a dose-dependent manner. In mice, emodin suppressed corneal inflammatory cell infiltration and inhibited the development of corneal neovascularization induced by alkali burn. Compared to those of the PBS-treated group, lower VEGFR2 expression and CD31 levels were found in the emodin-treated group. Emodin dramatically decreased the expression of VEGFR2, p-VEGFR2, p-Akt, p-STAT3, and p-P38 in VEGF-treated HUVEC.

Conclusion: This study provides a new avenue for evaluating the molecular mechanisms underlying corneal inflammation and neovascularization. Emodin might be a promising new therapeutic option for corneal alkali burns.

Keywords: alkali burn; corneal inflammation; corneal neovascularisation; emodin; signal transduction; vascular endothelial growth factor receptor-2.

MeSH terms

  • Animals
  • Burns, Chemical* / drug therapy
  • Burns, Chemical* / metabolism
  • Burns, Chemical* / pathology
  • Corneal Neovascularization* / drug therapy
  • Corneal Neovascularization* / genetics
  • Corneal Neovascularization* / metabolism
  • Disease Models, Animal
  • Emodin*
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Inflammation / drug therapy
  • Mice
  • Molecular Docking Simulation
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / genetics
  • Proto-Oncogene Proteins c-akt / metabolism
  • Signal Transduction
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism
  • Vascular Endothelial Growth Factor Receptor-2 / genetics
  • Vascular Endothelial Growth Factor Receptor-2 / metabolism

Substances

  • Vascular Endothelial Growth Factor A
  • Proto-Oncogene Proteins c-akt
  • Emodin
  • Vascular Endothelial Growth Factor Receptor-2